0001209191-19-034054.txt : 20190603 0001209191-19-034054.hdr.sgml : 20190603 20190603181747 ACCESSION NUMBER: 0001209191-19-034054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190530 FILED AS OF DATE: 20190603 DATE AS OF CHANGE: 20190603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parker Geoffrey M. CENTRAL INDEX KEY: 0001491874 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 19874707 MAIL ADDRESS: STREET 1: 15 RIORDAN PLACE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-30 0 0001340652 ChemoCentryx, Inc. CCXI 0001491874 Parker Geoffrey M. C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 1 0 0 0 Common Stock 2019-05-30 4 M 0 18010 6.00 A 85014 D Common Stock 2019-05-30 4 S 0 12815 12.002 D 72199 D Common Stock 99600 I Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust Common Stock 5000 I By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA Stock Option (right to buy) 6.00 2019-05-30 4 M 0 18010 D 2009-12-11 2019-12-11 Common Stock 18010 31990 D Shares sold are associated with stock options that will expire in December 2019. Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $11.85 to $12.115 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. As of May 30, 2019, and prior to this transaction, the exercised options were fully vested. Not applicable. /s/ Susan M. Kanaya, as Attorney-in-Fact 2019-06-03